Denmark vs Norway: Proportion of isolates with decreased susceptibility or resistance
Denmark
0
in 2018
Norway
0
in 2018
Denmark rank
15th
Norway rank
15th
Proportion of isolates with decreased susceptibility or resistance over time
- Denmark
- Norway
How they compare
Denmark currently reports 0 against 0 in Norway, a difference of 0.
The two have swapped places 1 time across 10 shared years of data; in 2009 it was Denmark ahead.
Denmark ranks 15th and Norway ranks 15th of 27 countries.
Denmark has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.13 | 0.9091 | 14.22 | Denmark |
| 2010s | 5.92 | 2.98 | 2.94 | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Denmark or Norway?
- Denmark, at 0 against 0 in Norway as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Denmark and Norway?
- 0, with Denmark ahead.
- How many years of comparable data are there for Denmark and Norway?
- 10 years are reported by both, from 2009 to 2018.
- How do Denmark and Norway rank globally for proportion of isolates with decreased susceptibility or resistance?
- Denmark ranks 15th and Norway ranks 15th of 27 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.